Niowave, Inc.

Niowave was founded in 2005 by former National Superconducting Cyclotron Laboratory researcher Terry Grimm. Since 2005, Niowave has performed over 100 cryogenic tests on over 25 different superconducting cryomodules at its two Lansing, Michigan facilities, and has become a worldwide leader in research, development, manufacturing, and operation of superconducting electron linear accelerators to produce medical and industrial radioisotopes.

Niowave’s highly skilled workforce was built by combining the scientific and technical expertise from nearby world-class universities, national laboratories, and the strong manufacturing industry in Michigan. In the company’s state-of-the-art facilities, Niowave produces multiple medical radioisotopes that are used to treat cancer.

This isotope production is achieved by their in-house production, testing, and operation of complete accelerator systems and cryomodules, accelerating cavities and components, electron guns/injectors, liquid helium refrigerators, and microwave power sources.

Since December 2022, Niowave has been running their isotope production accelerator and helium refrigerator with less than 10% downtime for maintenance and upgrades.